AI Science Tracker
EN

Gannan Medical University

1 discovery from 2024

Discoveries

Exploring non-invasive precision treatment in non-small cell lung cancer patients through deep learning radiomics across imaging features and molecular phenotypes

Source check: Source checked. Not independent scientific confirmation.

Finding: Radiomics model predicts lung-cancer invasion, staging, and molecular markers in an independent test cohort. This record is limited to the study result and does not establish independent replication or real-world benefit.

Technology: Deep-learning radiomics framework

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Methods specify the AI/learned analysis that enabled the case-specific result: Radiomics model predicts lung-cancer invasion, staging, and molecular markers in an independent test cohort.
Test and result
Radiomics model predicts lung-cancer invasion, staging, and molecular markers in an independent test cohort.
Limitation / still unknown
The source-checked evidence does not establish broader external validity or prospective benefit. Affiliation was not available in the retrieved trusted primary metadata.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10809593/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.